Evidence map›Paper›PMID 39849098›Full record

ArticleScientific reports2025

Associations of inferior frontal sulcal hyperintensities on brain MRI with cerebral small vessel disease, cognitive function, and depression symptoms.

Marc Dörner, Malte Pfister, Anthony Tyndall, Roland von Känel, Katja Neumann, Frank Schreiber, Philipp Arndt, Erelle Fuchs, Cornelia Garz, Wenzel Glanz and 20 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Marc DörnerGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany. marc.doerner@usz.ch.
Malte PfisterDepartment of Neurology, Otto-von-Guericke University, 39120, Magdeburg, Germany.
Anthony TyndallDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, 8091, Switzerland.
Roland von KänelDepartment of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Culmannstrasse 8, Zurich, 8091, Switzerland.
Katja NeumannDepartment of Neurology, Otto-von-Guericke University, 39120, Magdeburg, Germany.
Frank SchreiberGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Philipp ArndtGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Erelle FuchsDepartment of Neuroradiology, Otto-von-Guericke University, 39120, Magdeburg, Germany.
Cornelia GarzGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Wenzel GlanzGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Michaela ButrynGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Anna-Charlotte JohnDepartment of Neurology, Otto-von-Guericke University, 39120, Magdeburg, Germany.
Annkatrin HildebrandDepartment of Neurology, Otto-von-Guericke University, 39120, Magdeburg, Germany.
Sebastian EulerDepartment of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Culmannstrasse 8, Zurich, 8091, Switzerland.
Andreas B HofmannDepartment of Psychiatry, Psychotherapy, and Psychosomatics, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, 8032, Switzerland.
Lena MachetanzDepartment of Psychiatry, Psychotherapy, and Psychosomatics, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, 8032, Switzerland.
Johannes KirchebnerDepartment of Forensic Psychiatry, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, 8032, Switzerland.
Pawel TacikDepartment of Parkinson's Disease, Sleep and Movement Disorders, University Hospital Bonn, 53127, Bonn, Germany.
Alexander GrimmCenter for Neurology, Tuebingen University Hospital and Hertie-Institute for Clinical Brain Research, Eberhard Karls University, 72076, Tuebingen, Tuebingen, Germany.
Robin JansenDepartment of Neurology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany.
Marc PawlitzkiDepartment of Neurology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany.
Solveig HenneickeGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Valentina PerosaMassachusetts General Hospital, J. Philip Kistler Stroke Research Center, 02114, Boston, MA, Germany.
Bendix LabeitDepartment of Neurology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany.
Emrah DüzelGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Sven G MeuthDepartment of Neurology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany.
Stefan VielhaberDepartment of Neurology, Otto-von-Guericke University, 39120, Magdeburg, Germany.
Hendrik MatternGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Jose Bernal *German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.
Stefanie Schreiber *German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120, Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inferior frontal sulcal hyperintensities (IFSH) observed on fluid-attenuated inversion recovery (FLAIR) MRI have been proposed as indicators of elevated cerebrospinal fluid waste accumulation in cerebral small vessel disease (CSVD). However, to validate IFSH as a reliable imaging biomarker, further replication studies are required. The objective of this study was to investigate associations between IFSH and CSVD, and their potential repercussions, i.e., cognitive impairment and depression. We prospectively recruited 47 patients with CSVD and 29 cognitively normal controls (NC). IFSH were rated visually based on FLAIR MRI. Using different regression models, we explored the relationship between IFSH, group status (CSVD vs. NC), CSVD severity assessed with MRI, cognitive function, and symptoms of depression. Patients with CSVD were more likely to have higher IFSH scores compared to NC (OR 5.64, 95% CI 1.91-16.60), and greater CSVD severity on MRI predicted more severe IFSH (OR 1.47, 95% CI 1.14-1.88). Higher IFSH scores were associated with lower cognitive function (-0.96, 95% CI -1.81 to -0.10), and higher levels of depression (0.33, 95% CI 0.01-0.65). CSVD and IFSH may be tightly linked to each other, and the accumulation of waste products, indicated by IFSH, could have detrimental effects on cognitive function and symptoms of depression.

Indexed as

Cerebral Small Vessel DiseasesCognitionDepressionMagnetic Resonance ImagingAgedCase-Control StudiesFemaleHumansMaleMiddle AgedProspective StudiesCerebral amyloid angiopathyCerebral small vessel diseaseFluid-attenuated inversion recoveryGlymphatic systemHypertensive arteriopathyInferior frontal sulcal hyperintensity

Identifiers

PMID39849098
PMCPMC11758024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.